These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36190186)

  • 1. Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Billings P; Lawrence C; Lowe D; Hidalgo LG;
    Transplantation; 2023 Mar; 107(3):709-719. PubMed ID: 36190186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States.
    Gauthier PT; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Halloran PF;
    Transplantation; 2024 Apr; 108(4):898-910. PubMed ID: 38150492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study.
    Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J
    Transplantation; 2024 Sep; 108(9):1931-1942. PubMed ID: 38538559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.
    Kim HD; Bae H; Kang H; Lee H; Eum SH; Yang CW; Choi YJ; Chung BH; Oh EJ
    Front Immunol; 2024; 15():1433918. PubMed ID: 39044817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation.
    Halloran PF; Reeve J; Madill-Thomsen KS; Kaur N; Ahmed E; Cantos C; Al Haj Baddar N; Demko Z; Liang N; Swenerton RK; Zimmermann BG; Van Hummelen P; Prewett A; Rabinowitz M; Tabriziani H; Gauthier P; Billings P;
    Transplantation; 2022 Dec; 106(12):2435-2442. PubMed ID: 35765145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications.
    Akifova A; Budde K; Oellerich M; Beck J; Bornemann-Kolatzki K; Schütz E; Osmanodja B
    Transpl Int; 2024; 37():13239. PubMed ID: 39188271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.
    Moeller CM; Oren D; Fernandez Valledor A; Rubinstein G; Lotan D; Mehlman Y; Slomovich S; Rahman S; Lee C; Baranowska J; Regan M; Elad B; DeFilippis EM; Hennecken C; Salazar R; Raikhelkar J; Clerkin KJ; Fried J; Lin E; Bae D; Oh KT; Latif F; Topkara VK; Naka Y; Takeda K; Majure D; Uriel N; Sayer G
    Clin Transplant; 2024 Oct; 38(10):e15479. PubMed ID: 39422086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients.
    Jordan SC; Bunnapradist S; Bromberg JS; Langone AJ; Hiller D; Yee JP; Sninsky JJ; Woodward RN; Matas AJ
    Transplant Direct; 2018 Sep; 4(9):e379. PubMed ID: 30234148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Noninvasive Surveillance for Acute Rejection in Pediatric Heart Transplant Recipients: A Real-World Analysis of Donor-Derived Cell-Free DNA-Based Surveillance Protocol.
    Akabas L; Bravo SA; Zhang Y; Simonelli A; Zuckerman WA; Richmond ME; Lytrivi ID
    Clin Transplant; 2024 Oct; 38(10):e15481. PubMed ID: 39412485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
    Boonpheng B; De Castro ICC; Ng YH; Blosser C; Bakthavatsalam R; Gimferrer I; Smith K; Leca N
    Clin Transplant; 2023 May; 37(5):e14936. PubMed ID: 36787372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.